U.S. Startup Offers Genetic Testing of Embryos to Predict IQ, Raising Ethical Concerns! 🧬

News & Articles
1

Summary:

  1. Startup Launch
    Heliospect Genomics, a U.S. startup, is offering wealthy couples the option to screen embryos for IQ, raising significant ethical questions surrounding genetic enhancement.

  2. High Costs for Services
    The company is reportedly charging up to $50,000 for testing 100 embryos, with claims of potentially increasing a child’s IQ by over six points based on genetic predictions.

  3. Marketing Controversies
    Undercover footage reveals the company promoting its services by suggesting couples can rank embryos based on various traits, including intelligence, sex, height, and health risks.

  4. Legal and Ethical Implications
    While embryo selection based on predicted IQ is illegal in the UK, it remains legal in the U.S., where regulations on embryology are less stringent, though such services are not yet commercially available.

  5. Expert Concerns
    Leading geneticists and bioethicists have expressed alarm over the moral and medical implications of such practices, emphasizing the potential societal impacts of genetic selection.

Read more at: The Guardian